<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Marinescu M</submitter><funding>Deutsche Arthrose-Hilfe</funding><pagination>339</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12470832</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(9)</volume><pubmed_abstract>Osteoarthritis (OA), the most common joint disease, is marked by cartilage degradation and chronic inflammation. While 45S5-bioactive glass (45S5-BG) is well-established in bone regeneration and has been suggested to exert immunomodulatory effects, its impact on OA chondrocytes remains largely unexplored. Therefore, this in vitro study investigated the effects of 45S5-BG microparticles (0.125 mg/mL) on chondrocytes derived from OA patients, evaluating its therapeutic potential in OA. Chondrocytes were cultured with or without 45S5-BG for 1 and 7 days. Gene expression of cartilage markers, cytokines, matrix metalloproteinases (MMPs), and toll-like receptors (TLRs) was analyzed by qPCR. Protein levels were assessed by ELISA. 45S5-BG stimulation significantly altered chondrocyte activity, inducing upregulation of IL-6, IL-1β, TNF-α, MMP-1/-3/-13, and TLR4. Expression of ACAN and COL2A1 was reduced, while COL10A1-a marker of chondrocyte hypertrophy-was significantly increased at day 1. These findings show a catabolic and pro-inflammatory shift in chondrocyte phenotype upon 45S5-BG exposure, showing no therapeutic benefit of 45S5-BG on OA chondrocytes. However, considering the pronounced effects on chondrocyte activity and the well-established bioactivity and biocompatibility of 45S5-BG, our findings suggest that modified BG formulations could be developed to enhance chondroprotective and anti-inflammatory properties, warranting further investigation in co-culture and in vivo models.</pubmed_abstract><journal>Journal of functional biomaterials</journal><pubmed_title>Impact of 45S5-Bioactive Glass on Chondrocytes in Knee Osteoarthritis-In Vitro Study Exploring Cellular Responses.</pubmed_title><pmcid>PMC12470832</pmcid><funding_grant_id>P515-A623</funding_grant_id><pubmed_authors>Westhauser F</pubmed_authors><pubmed_authors>Mayakrishnan R</pubmed_authors><pubmed_authors>Moradi B</pubmed_authors><pubmed_authors>Fellenberg J</pubmed_authors><pubmed_authors>Renkawitz T</pubmed_authors><pubmed_authors>Platzer H</pubmed_authors><pubmed_authors>Hagmann S</pubmed_authors><pubmed_authors>Gantz S</pubmed_authors><pubmed_authors>Marinescu M</pubmed_authors><pubmed_authors>Boccaccini AR</pubmed_authors><pubmed_authors>Tripel E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of 45S5-Bioactive Glass on Chondrocytes in Knee Osteoarthritis-In Vitro Study Exploring Cellular Responses.</name><description>Osteoarthritis (OA), the most common joint disease, is marked by cartilage degradation and chronic inflammation. While 45S5-bioactive glass (45S5-BG) is well-established in bone regeneration and has been suggested to exert immunomodulatory effects, its impact on OA chondrocytes remains largely unexplored. Therefore, this in vitro study investigated the effects of 45S5-BG microparticles (0.125 mg/mL) on chondrocytes derived from OA patients, evaluating its therapeutic potential in OA. Chondrocytes were cultured with or without 45S5-BG for 1 and 7 days. Gene expression of cartilage markers, cytokines, matrix metalloproteinases (MMPs), and toll-like receptors (TLRs) was analyzed by qPCR. Protein levels were assessed by ELISA. 45S5-BG stimulation significantly altered chondrocyte activity, inducing upregulation of IL-6, IL-1β, TNF-α, MMP-1/-3/-13, and TLR4. Expression of ACAN and COL2A1 was reduced, while COL10A1-a marker of chondrocyte hypertrophy-was significantly increased at day 1. These findings show a catabolic and pro-inflammatory shift in chondrocyte phenotype upon 45S5-BG exposure, showing no therapeutic benefit of 45S5-BG on OA chondrocytes. However, considering the pronounced effects on chondrocyte activity and the well-established bioactivity and biocompatibility of 45S5-BG, our findings suggest that modified BG formulations could be developed to enhance chondroprotective and anti-inflammatory properties, warranting further investigation in co-culture and in vivo models.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-01T03:20:18.186Z</modification><creation>2026-05-01T03:10:57.113Z</creation></dates><accession>S-EPMC12470832</accession><cross_references><pubmed>41003410</pubmed><doi>10.3390/jfb16090339</doi></cross_references></HashMap>